ArticleSchmerz (Berlin, Germany)2010
[Validation of the German version of the Regional Pain Scale for the diagnosis of fibromyalgia syndrome].
Article in Schmerz (Berlin, Germany), 2010. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 15 papers, 1 of them a synthesis that pooled it.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
15 citing papers in PubMed, 1 synthesis or guideline pooled it, 33 citations in OpenAlex.
- [Fibromyalgia syndrome. Definition, classification, clinical diagnosis and prognosis].Schmerz (Berlin, Germany) · 2012Guideline
- Understanding Health-related quality of life in rheumatologic diseases: insights from PROMISJournal of patient-reported outcomes · 2026Article
- Painkiller intake and problematic health literacy in sport and music students - A cross-sectional study.Scientific reports · 2024Article
- Article
- Measuring PROMIS pain interference in German patients with chronic conditions: calibration, validation, and cross-cultural use of item parameters.Quality of life research : an international journal of quality of life aspects of treatment, care and rehabilitation · 2023Article
- Prevalence of Biopsychosocial Factors of Pain in 865 Sports Students of the Dach (Germany, Austria, Switzerland) Region - A Cross-Sectional Survey.Journal of sports science & medicine · 2020Article
- Classifying Fibromyalgia Syndrome as a Mental Disorder?-An Ambulatory Assessment Study.International journal of behavioral medicine · 2017Article
- Pain experiences of patients with musculoskeletal pain + central sensitization: A comparative Group Delphi Study.PloS one · 2017Article
- Prevalence of self-reported jaw pain in Germany: two cross-sectional surveys of the general German population.Clinical oral investigations · 2016Article
- [Chronic pain, pain disease, and satisfaction of patients with pain treatment in Germany. Results of a representative population survey].Schmerz (Berlin, Germany) · 2014Article
- [Are members of fibromyalgia syndrome self-help groups "different"? Demographic and clinical characteristics of members and non-members of fibromyalgia syndrome self-help groups].Zeitschrift fur Rheumatologie · 2013Article
- [Prevalence of chronic pain in Germany. A representative survey of the general population].Schmerz (Berlin, Germany) · 2013Article
- [German fibromyalgia consumer reports. Benefits and harms of fibromyalgia syndrome therapies].Schmerz (Berlin, Germany) · 2012Article
- Article
- [Treatment and healthcare costs of fibromyalgia syndrome in Germany: analysis of the data of the Barmer health insurance (BEK) from 2008-2009].Schmerz (Berlin, Germany) · 2011Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
10 authors at 4 institutions in 1 country.
Funding
No grant is acknowledged in the PubMed record.
Abstract
objectiveUse of the American College of Rheumatology classification criteria for the clinical diagnosis of fibromyalgia syndrome (FMS) is under debate. The Regional Pain Scale (RPS) had been developed for the diagnosis of FMS in clinical practice and in survey settings (survey criteria of FMS). So far a German version has not been validated.
methodsA total of 216 patients with FMS, 53 with active rheumatoid arthritis (RA) and 60 with depressive disorder, recruited from clinical institutions completed the RPS. Forty-three patients with FMS filled in the RPS within 8 weeks a second time.
resultsThe intraclass coefficient of FMS diagnosis after 8 weeks was 0.78 (test-retest reliability). The 7-day interval of pain was criticized by physicians. The absence of some articular pain regions was criticized by patients (face validity). The concordance of FMS diagnoses to survey and ACR criteria was 84.7% (+/-1.1); 45.3% of the patients with RA and 38.3% of the patients with depressive disorder met the survey criteria of FMS (discriminant validity).
conclusionThe RPS has good reliability and convergent validity, but limited discriminant validity. The RPS is suited as a screening instrument for the diagnosis of FMS in clinical practice.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.